User profiles for Peter A. Merkel

Peter Merkel

Verified email at upenn.edu
Cited by 60686

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative

…, S Jimenez, B Kahaleh, PA Merkel… - Arthritis & …, 2013 - Wiley Online Library
Objective The 1980 American College of Rheumatology (ACR) classification criteria for
systemic sclerosis (SSc) lack sensitivity for early SSc and limited cutaneous SSc. The present …

[HTML][HTML] Rituximab versus cyclophosphamide for ANCA-associated vasculitis

JH Stone, PA Merkel, R Spiera, P Seo… - … England Journal of …, 2010 - Mass Medical Soc
Background Cyclophosphamide and glucocorticoids have been the cornerstone of
remission-induction therapy for severe antineutrophil cytoplasmic antibody (ANCA)−associated …

Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I

…, HM Kremers, MD Mayes, PA Merkel… - Arthritis & …, 2008 - Wiley Online Library
Objective. To provide a single source for the best available estimates of the US prevalence of
and number of individuals affected by arthritis overall, rheumatoid arthritis, juvenile arthritis, …

2021 American College of Rheumatology/Vasculitis Foundation guideline for the management of antineutrophil cytoplasmic antibody–associated vasculitis

…, MF Ibarra, LF Imundo, S Kim, PA Merkel… - Arthritis & …, 2021 - Wiley Online Library
Objective To provide evidence‐based recommendations and expert guidance for the
management of antineutrophil cytoplasmic antibody–associated vasculitis (AAV), including …

EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis

…, MA Little, RA Luqmani, A Mahr, PA Merkel… - Annals of the …, 2016 - ard.bmj.com
In this article, the 2009 European League Against Rheumatism (EULAR) recommendations
for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (…

EULAR recommendations for the management of primary small and medium vessel vasculitis

…, D Jayne, CGM Kallenberg, PA Merkel… - Annals of the …, 2009 - ard.bmj.com
Objectives: To develop European League Against Rheumatism (EULAR) recommendations
for the management of small and medium vessel vasculitis. Methods: An expert group (…

ANCA-associated vasculitis

…, DR Jayne, J Kullman, PA Lyons, PA Merkel… - Nature reviews Disease …, 2020 - nature.com
The anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs) are a group
of disorders involving severe, systemic, small-vessel vasculitis and are characterized by …

2021 American College of Rheumatology/Vasculitis Foundation guideline for the management of giant cell arteritis and Takayasu arteritis

…, MF Ibarra, LF Imundo, S Kim, PA Merkel… - Arthritis & …, 2021 - Wiley Online Library
Objective To provide evidence‐based recommendations and expert guidance for the
management of giant cell arteritis (GCA) and Takayasu arteritis (TAK) as exemplars of large vessel …

[HTML][HTML] Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis

…, A Klion, CA Langford, PA Merkel… - … England Journal of …, 2017 - Mass Medical Soc
Background Eosinophilic granulomatosis with polyangiitis is an eosinophilic vasculitis.
Mepolizumab, an anti–interleukin-5 monoclonal antibody, reduces blood eosinophil counts and …

2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis

…, A Hutchings, RA Watts, PA Merkel… - Arthritis & …, 2022 - Wiley Online Library
Objective To develop and validate revised classification criteria for granulomatosis with
polyangiitis (GPA). Methods Patients with vasculitis or comparator diseases were recruited into …